Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176602 | SCV000228281 | uncertain significance | not provided | 2016-12-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088829 | SCV001053289 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453627 | SCV002611586 | likely benign | Cardiovascular phenotype | 2021-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000176602 | SCV004152354 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Clinical Genetics, |
RCV001699054 | SCV001924824 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000176602 | SCV001954896 | likely benign | not provided | no assertion criteria provided | clinical testing |